(1)Constant Currency ("CC") represents year-over-year changes resulting from translating 2022 financial data into USD using 2021 exchange rates; (2)See reconciliation of Non-GAAP Measures included in Form 8-K dated February 16, 2023; (3)Includes the 2022 results of RocketPower and Pediatric Therapeutic Services ("PTS"), which were acquired as of March 7, 2022 and May 2, 2022, respectively. RocketPower was included in the reported results of operations in Outsourcing & Consulting and PTS was included in the reported results of operations in Education, from the date of acquisition; (4)Excludes 2022 results of RocketPower and PTS; (5)Excludes the results of our Russian operations following the completion of the sales transaction in Q3 2022; (6)Gain on investment in Persol Holdings of $50.0 million, $34.7 million net of tax, or $0.87 per share in Q4 2021. Loss on investment in Persol Holdings of $67.2 million, $48.8 million net of tax, or $1.28 per share in 2022 and gain on investment in Persol Holdings of $121.8 million, $84.5 million net of tax, or $2.12 per share in 2021; (7)Gain on sale of assets includes gains from the sale of real property of $0.9 million, $0.6 million net of tax, or $0.02 per share in Q4 2022 and gains from the sale of real property of $6.2 million, $4.6 million net of tax, or $0.12 per share in 2022; (8)Goodwill impairment charge of $10.3 million, $8.5 million net of tax, or $0.23 per share in Q4 2022 and $41.0 million, $33.9 million net of tax, or $0.89 per share in 2022; (9)Restructuring charges of $4.1 million, $3.1 million net of tax, or $0.08 per share in Q4 2021 and $4.0 million, $3.0 million net of tax, or $0.07 per share in 2021; (10)Gain on insurance settlement of $19.0 million, $14.2 million net of tax, or $0.36 per share in Q4 2021; (11)Loss on foreign currency matters includes of $20.4 million currency translation from liquidation of subsidiary, partially offset by $5.5 million foreign exchange gain, $16.4 million net of tax, or $0.43 per share in 2022; (12)Loss on disposal related to the sale of our Russian operations of $18.7 million, $18.7 million net of tax, or $0.49 per share in 2022; (13)U.S. credit facilities, net of standby letters of credit related to workers’ compensation; (14)Kelly size and margin profiles are based on 2022 full year results; (15)Kelly Education revenue and GP rate was $0.7B and 16.6%, respectively, including the results of PTS on a proforma basis; (16)Kelly OCG revenue and GP rate was $0.5B and 36.7%, respectively, including the results of RocketPower on a proforma basis; (17)Managed Service Provider (“MSP”); Recruitment Process Outsourcing (“RPO”); Payroll Process Outsourcing (“PPO”).